Peter Langguth is Pharmaceutical scientist by training and Professor of Pharmaceutical Technology and Biopharmaceutics at the School of Pharmacy and Biochemistry, Johannes Gutenberg University Mainz, Germany. He did undergraduate studies in Pharmacy at the Johann Wolfgang Goethe University in Frankfurt, where he also received a Ph.D. in 1985 with Prof. Ernst Mutschler on the improvement of transdermal and intestinal permeability of furosemide prodrugs. Until 1988 he was Post-doctoral Research Fellow in Pharmacokinetics in the group of Prof. Edward R. Garrett at the University of Florida in Gainesville and from 1989 until 1995 he was Senior Research Fellow at the Department of Pharmaceutical Technology, Swiss Federal Institute of Technology (ETH) in Zürich, Switzerland with Prof. Hans P. Merkle. In 1995 he received the Venia legendi (Habilitation) in Pharmaceutical Technology and Biopharmaceutics from the ETH. In 1996 Prof. Langguth joined Astra Hässle AB in Mölndal, Sweden, as Group Leader in Drug Absorption Research.
Since 1998 Dr. Langguth is Head of the Department of Pharmaceutical Technology and Biopharmaceutics at the Johannes Gutenberg University in Mainz. From 2003 to 2005 he was Associate Dean of the Faculty of Chemistry and Pharmacy and from 2005 to 2008 he served as Dean for the Faculty of Chemistry, Pharmacy and Earth Sciences at that University.
Dr. Langguth has published more than 200 articles in the areas of Biopharmaceutics and Pharmaceutical Technology and Drug Delivery. He has co-editored the book “Biopharmazie” (Wiley-VCH, 2004), and he is Co-editor of the Scientific Commentary to the European Pharmacopoeia. His research interests include membrane transport of drugs when relevant for bioavailability, pharmacokinetics and drug targeting, in vitro / in vivo correlations and biowaivers, dosage form design and pharmaceutical quality.